Advances in the management of esophageal cancer
Marmara Medical Journal · 2015
DOI: 10.5472/mmj.10059 ↗Kurz gefasst
Fachartikel in der Zeitschrift Marmara Medical Journal, 2015. Verfasst von Bruce D. MINSKY.
Abstract (Originalsprache)
The management of clinical stage III and IVa esophagealcancer has evolved in the past 2 decades. Based on the Crosstrial, neoadjuvant chemoradiation, followed by surgicalresection has become standard. For medically inoperable,definitive chemoradiation is most commonly used. Thestandard radiation dose is 50.4 Gy although trials of doseescalationare ongoing. At the current time, there are nodefinitive biomarkers to predict response.Keywords: Esophageal cancer, Radiation therapy,Chemotherapy, Dose-escalation
Zitieren
APA
MINSKY, B. D. (2015). Advances in the management of esophageal cancer. Marmara Medical Journal. https://doi.org/10.5472/mmj.10059
Vancouver
MINSKY BD. Advances in the management of esophageal cancer. Marmara Medical Journal. 2015. doi:10.5472/mmj.10059
BibTeX
@article{MINSKY2015,
author = {MINSKY, Bruce D.},
title = {Advances in the management of esophageal cancer},
journal = {Marmara Medical Journal},
year = {2015},
doi = {10.5472/mmj.10059}
}
EUVIMED